Get our Editor-in-Chief Michelle Itano's BioTechniques Q1 2026 highlights, featuring an optimized Southern blot protocol and ...

OGM VIA customers represent a meaningful software revenue stream and a natural on-ramp to broader Bionano Genomics, Inc.

The global digital dentistry market is growing steadily, expected to be valued at around US$ 7.2 billion in 2026 and ...

Infectious keratitis remains a leading cause of corneal blindness and visual impairment worldwide, with bacterial, fungal, ...

Good day, and welcome to the Bionano Fourth Quarter and Full Year 2025 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Webb ...

Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 Earnings Call Transcript March 23, 2026 Bionano Genomics, Inc. reports earnings ...

Two decades of cloning experiments in mice have produced a striking pattern: animals created through somatic cell nuclear ...

Rising Demand for Cosmetic and Restorative DentistryThe growing demand for cosmetic and restorative dental procedures is a major driver of the digital dentistry market. Increasing awareness of oral he ...

Understand the importance of targeted assays in personalised medicine and how early decisions shape clinical outcomes.

Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.

To address the demand for rapid, highly specific therapeutic candidates, Creative Biolabs has optimized its comprehensive ...

In the continuously advancing field of genetics, particularly within human and medical genomics, the last ten years have seen an array of significant achievements and breakthroughs. These developments ...